Click on image to view larger version.

Figure 11 Cumulative rate of recurrent myocardial infarction or death from cardiac causes among statin-treated patients according to achieved levels of both low-density lipoprotein (LDL) cholesterol and high-sensitivity C-reactive protein (CRP) in the TIMI 22 trial. Adapted with permission from Ridker et al. (106). TIMI = Thrombolysis In Myocardial Infarction.